Rossari Biotech says the proceeds from the IPO will be used to primarily repay debt and fund working capital requirements, along with general corporate purposes.
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
The bank plans to raise up to Rs 500 crore by issue of equity shares to qualified institutional buyers through qualified institutional plac...
-
In July, HCL Technologies had announced a Rs 4,000 crore buyback programme for FY19 at a price of Rs 1,100 per equity share.
Hey...Great information thanks for sharing such a valuable information
ReplyDeleteSBI card and payment service IPO
Rosary Biotech IPO
Reliance Industries